Fusion Pharmaceuticals In... (FUSN)
NASDAQ: FUSN
· Real-Time Price · USD
21.55
0.03 (0.14%)
At close: Jun 03, 2024, 10:00 PM
Fusion Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -104.28M | -94.9M | -91.33M | -98.1M | -91.99M | -87.61M | -80.23M | -75.65M | -83.43M | -81.05M | -77.2M | -67.76M | -85.64M |
Depreciation & Amortization | 1.43M | 1.34M | 1.23M | 1.1M | 979K | 909K | 845K | 788K | 726K | 634K | 559K | 477K | 421K |
Stock-Based Compensation | 13.81M | 12.44M | 11.97M | 11.67M | 11.36M | 10.84M | 10.43M | 10.11M | 9.52M | 8.6M | 7.58M | 6.45M | 4.73M |
Other Working Capital | 4.03M | 2.87M | 2.31M | 5.89M | 1.22M | 2.96M | 963K | 514K | 208K | -5.51M | -3.51M | -8.04M | -4.82M |
Other Non-Cash Items | 5.66M | 755.75K | -1.09M | 82K | 1.02M | 2.08M | 2.81M | 2.14M | 10.95M | 10.7M | 15.53M | 14.84M | 37.25M |
Deferred Income Tax | 935.07K | 846.07K | -2.72M | -3.76M | -3.32M | -3.16M | -2.83M | -1.17M | -820K | -31K | -258K | -5K | 5.96M |
Change in Working Capital | 4.56M | -1.29M | -1.27M | 3M | -1.79M | 3.66M | -1.26M | -6.34M | -7.06M | -14.6M | -8.71M | -7.85M | -5.46M |
Operating Cash Flow | -82.66M | -80.79M | -83.22M | -86.01M | -83.74M | -73.28M | -70.24M | -70.12M | -70.11M | -75.74M | -62.49M | -53.85M | -42.74M |
Capital Expenditures | -3.96M | -3.84M | -3.36M | -3.1M | -2.77M | -2.14M | -1.73M | -1.67M | -1.5M | -1.49M | -1.01M | -1.53M | -1.49M |
Cash Acquisitions | -37.1M | -13.8M | 77.1M | 53.43M | 17.8M | -5.5M | -47.49M | -10.02M | n/a | n/a | -9.7M | -9.7M | -9.7M |
Purchase of Investments | -283.95M | -227.76M | -260.99M | -248.11M | -210.25M | -165.16M | -90.54M | -89.88M | -123.72M | -172.47M | -322.17M | -296.88M | -230.82M |
Sales Maturities Of Investments | 199.84M | 189.39M | 183.9M | 194.68M | 192.45M | 190.38M | 189.19M | 183.44M | 211.13M | 211.73M | 174.96M | 117.29M | 47.36M |
Other Investing Acitivies | -31.93M | 13.8M | -77.1M | -53.43M | -17.8M | 5.5M | 47.49M | 10.02M | n/a | n/a | 9.7M | -44.59M | -44.59M |
Investing Cash Flow | -88.06M | -42.22M | -80.45M | -56.53M | -20.57M | 23.09M | 96.92M | 91.89M | 85.9M | 37.77M | -148.23M | -235.41M | -239.24M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 1.28M | 1.28M | 1.28M | 1.28M | n/a | n/a | n/a | n/a | 1.1M | 1.1M | 1.1M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 146.5M | 142.01M | 84.28M | 112.86M | 98.54M | 40.73M | 40.55M | 11.7M | 1.93M | 347K | 453K | -1.9M | 255.73M |
Financial Cash Flow | 144.86M | 140.37M | 84.28M | 112.86M | 98.54M | 40.73M | 40.55M | 11.7M | 1.93M | 347K | 453K | -1.9M | 255.73M |
Net Cash Flow | -25.78M | 17.44M | -79.39M | -29.68M | -5.77M | -9.46M | 67.23M | 33.47M | 17.7M | -37.62M | -210.27M | -291.16M | -26.23M |
Free Cash Flow | -86.62M | -84.64M | -86.58M | -89.11M | -86.51M | -75.42M | -71.97M | -71.79M | -71.62M | -77.23M | -63.51M | -55.39M | -44.24M |